SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 80 filers reported holding SAVARA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $833,000 | -64.4% | 110,000 | -47.5% | 0.09% | -65.1% |
| Q3 2018 | $2,339,000 | -21.2% | 209,596 | +4.8% | 0.27% | -22.7% |
| Q4 2017 | $2,968,000 | -39.7% | 200,000 | -62.0% | 0.35% | -50.4% |
| Q3 2017 | $4,921,000 | +59.0% | 526,315 | 0.0% | 0.70% | +33.5% |
| Q2 2017 | $3,095,000 | – | 526,315 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 3,313,602 | $12,525,416 | 47.59% |
| NEA Management Company, LLC | 24,471,264 | $92,501,378 | 7.14% |
| Bain Capital Life Sciences Investors, LLC | 14,232,751 | $53,799,799 | 6.02% |
| TCG Crossover Management, LLC | 10,000,000 | $37,800,000 | 5.57% |
| VR Adviser, LLC | 7,184,865 | $27,158,790 | 2.86% |
| Affinity Asset Advisors, LLC | 1,150,000 | $4,347,000 | 1.22% |
| Sio Capital Management, LLC | 896,250 | $3,387,825 | 1.05% |
| Frazier Life Sciences Management, L.P. | 4,000,000 | $15,120,000 | 1.00% |
| Vivo Capital, LLC | 1,913,349 | $7,232,459 | 0.79% |
| Nantahala Capital Management | 1,039,364 | $3,928,796 | 0.34% |